Accolade and Transcarent announce HSR waiting period expiration for merger
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2025
0mins
Should l Buy ?
Merger Announcement: Accolade and Transcarent have announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act regarding their merger.
Completion Timeline: The merger is expected to be completed in Q2, pending Accolade stockholder approval and other customary closing conditions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
